Hasta La Gadget!

“We’ve known this. For a long time,” CNN’s chief medical correspondent said of Gov. Brian Kemp’s admission.

Tesla and SpaceX CEO Elon Musk said he’d be sending desperately needed “FDA-approved ventilators” to hard-hit hospitals across the nation dealing with the coronavirus crisis—but they haven’t been the high-grade kind needed to keep intensive care patients alive. Instead, those sent off so far appear to be Bilevel…

Read more…

The Duchess of Sussex’s first post-royal project arrives on April 3.

At the moment, there is no known vaccine that works against the COVID-19 virus. Researchers are working on several potential solutions, but there is nothing definitive yet. However, to help speed up the process, several scientists around the world are now exploring older vaccines to see if it can help.

The vaccine in question is known as the Bacille Calmette-Guerin (BCG) vaccine and was introduced back in the 1920s to fight against tuberculosis. In fact, some countries in Asia such as Singapore and Malaysia had previously made it mandatory for newborns to receive the vaccine, and once again when children hit 12 years old.

The reason that researchers are exploring this particular vaccine is because unlike other vaccines that only protect against a particular disease, the BCG vaccine also helps boost the immune system in general. A study found that there were 50% lower mortality rates in children who received the vaccine compared to those who did not, which is a much bigger drop in deaths that can be explained by a reduction in tuberculosis cases.

However, whether or not the BCG vaccine will be able to work effectively against the COVID-19 virus remains to be seen. The researchers are saying that it will probably be months before they get the results back from the trial, so maybe don’t get your hopes up just yet.

Researchers Test Effectiveness Of Century-Old Tuberculosis Vaccine Against The COVID-19 Virus

, original content from Ubergizmo. Read our Copyrights and terms of use.

Right now the race is on to find a vaccine for the coronavirus outbreak that has impacted the world. Unfortunately, there is no known vaccine in the market yet, but there have been great efforts made by companies in which some potential vaccines have already been sent for human trials.

It looks like we might be able to add another to the list, thanks to the work of researchers at the University of Pittsburgh School of Medicine who have created a potential new effective vaccine against the virus. The vaccine that they created was tested on mice and based on their initial findings, it managed to produce enough antibodies in the host’s system to neutralize the virus within two weeks of injection.

According to Andrea Gambotto, associate professor of surgery at the Pittsburgh School of Medicine, “These two viruses, which are closely related to [Covid-19], teach us that a particular protein, called a spike protein, is important for inducing immunity against the virus. We knew exactly where to fight this new virus.”

The method of delivery involves a patch that is placed on the skin. The patch contains 400 tiny microneedles that can inject the vaccine into the skin where the immune reaction is the strongest. The patch is made using sugar and protein pieces and will eventually dissolve away. It is unclear how this will work on humans, but so far it appears to be promising as the researchers’ work have since been peer reviewed by other scientists outside of the university.

Potential Coronavirus Vaccine Produces Enough Antibodies To Fight Off The Virus

, original content from Ubergizmo. Read our Copyrights and terms of use.